Efficacy of Extracorporeal Shock Wave Therapy on Carpal Tunnel Syndrome Post Mastectomy Lymphedema

Launched by CAIRO UNIVERSITY · Nov 9, 2023

Keywords

ClinConnect Summary

This clinical trial is studying the effectiveness of a treatment called Extracorporeal Shock Wave Therapy for women who have Carpal Tunnel Syndrome (CTS) after experiencing lymphedema following a mastectomy. CTS can cause symptoms like wrist pain, numbness, and tingling in the hand, which can be especially bothersome. The trial is looking for female participants aged 40 to 60 who have had these symptoms for at least three months and have lymphedema in one or both arms.

If eligible, participants will receive the therapy over four weeks, and their experience will be closely monitored. To participate, women must not have any infections in their hands or certain medical conditions that could complicate the study. This research aims to determine if this therapy can help relieve the uncomfortable symptoms of CTS, improving the quality of life for those affected. All participants will provide informed consent to ensure they understand what the trial entails and their rights are protected.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • All participants could be considered and enrolled if they conformed to the diagnosis of CTS, with clinical symptoms for at least 3 months.
• The clinical symptoms and signs for the diagnosis of CTS were as follows:
• • 1. Paresthesias and painful swelling with weakness of the affected hand, exacerbated while sleeping or by repetitive use of the wrist, which would be relieved by shaking the hand with postural change.
• • 2. Sensory loss with numbness in the regions of the hand innervated by the median nerve;
• • 3. Impaired motor function with atrophy of the median nerve-innervated thenar muscles.
• • 4. Positive Tinel's sign.
• The subject selection will be according to the following criteria:
• • Female patient their age range between 40-60 years.
• • Symptoms of CTS as pain, tingling sensation for at least 3 months.
• • Unilateral or bilateral Lymphedema following mastectomy
• • All patients enrolled to the study will have their informed consent.
• Exclusion Criteria:
• * The potential participants will be excluded if they meet one of the following criteria:
• • Local infections at the hand level.
• • Patients with prior medical histories of cardiac arrhythmias.
• • Patient with venous thrombosis.
• • Areas of skin with lesions and impaired sensation
• • Other diseases that cause significant swelling.
• • During pregnancy and breastfeeding.